Zoetis Inc.

ZTS · Healthcare · · USD

75.81 USD

0.00 (-0.63%)

● Updated 2026-09-07 22:05 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score HOLD Long-term (Investment)

/ 100

Technical 50

Trend & RS 30

Momentum 27

Fundamental 83

Macro 64

Liquidity 42

Component	Score	Weight
Technical	50.0	10%
Trend & RS	29.8	10%
Momentum	26.9	5%
Fundamental	83.1	40%
Macro	64.4	15%
Liquidity	42.5	20%

Trade Setup

Entry	75.81
Stop Loss	70.81 (6.6%)
Target 1 (1:1)	80.81 (+6.6%)
Target 2 (2:1)	85.81 (+13.2%)

ATR(14)	2.50 (3.3%)
Risk per Share	5.00
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	78.3	+1.13
Momentum	26.9	-0.92
Quality	83.1	+1.32
Composite	62.8

Quality Scores

Piotroski F-Score 6 /9 — Average

✓ ✓ ✗ ✗ ✗ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 4.98 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	12.4	22.0	-44% below
P/B Ratio	N/A	4.0	Inline
Dividend Yield	2.8%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Fairly Valued

Intrinsic Value

75.67

Market Price

75.81

Upside

-0.2%

Margin of Safety	-0.2%
Stage 1 PV (5yr FCF)	8,339,463,891
Terminal Value PV	22,930,549,300
Total Enterprise Value	31,270,013,191

Assumptions

Base FCF	2,026,448,544
Growth Rate (5yr)	2.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

39.9%

Full Kelly

19.95%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 61/100. Estimated win rate 58%, avg win 8.6%, avg loss 3.8%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary BUY

Bullish Signals

Bearish Signals

48.92

RSI(14)

0.1817

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↓ FALLING (-8.6% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (60d since high)
Sector Outperformance	-11.7% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	48.92	NEUTRAL
Macd	0.1817	BULLISH
Ma Cross	75.42 / 102.04	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		BELOW SMA200
Bollinger		MIDDLE
Volume	0.83x	NORMAL

Key Levels

Level	Price
52-Week High	152.97
Bollinger Upper	78.77
SMA(200)	102.04
SMA(50)	75.42
SMA(20)	75.83
Current Price	75.81
Bollinger Lower	72.9
52-Week Low	71.00
ATR(14)	2.5

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

Insufficient data for Wyckoff analysis.

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.16x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.8x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.89x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.62x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.83x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	76.75	Above Kijun
Kijun-sen (26)	75.59	Base line
Senkou A	76.17	Leading span A
Senkou B	75.57	Leading span B
Cloud	75.57 – 76.17	Bullish (Green)
Price vs Cloud	75.81	Inside Cloud
Chikou Span	77.29	Bearish
Alignment Score	2/4	NEUTRAL